Last Updated September 17, 2026
Conditions Center · Neurological · Social Security Disability
Also called Huntington disease, HD, Huntington chorea.
Huntington’s disease can support SSDI or SSI under Listing 11.17, through Listing 12.02 when effects are solely cognitive, or through RFC. Adult-onset and juvenile-onset Huntington disease are on the current Compassionate Allowances list, which can speed processing. A laboratory CAG-repeat result without clinical disease, or a family history alone, is not an approval.
What is Huntington’s Disease?
NINDS describes Huntington’s disease as an inherited neurodegenerative disorder that causes progressive motor, cognitive, and psychiatric symptoms. Adult-onset disease usually begins in mid-adult years; juvenile-onset disease begins earlier and may look different clinically. Chorea, dystonia, impaired voluntary movement, decline in thinking, depression, and irritability are common. There is no current cure.
Common symptoms of Huntington’s Disease
- Involuntary movements (chorea) or impaired voluntary motor control
- Unsteady gait, falls, or reduced fine motor control
- Slowing of thinking, planning, or speech
- Irritability, depression, or other psychiatric symptoms
- Weight loss, swallowing difficulty, or reduced self-care as the disease advances
How can Huntington’s Disease affect a person’s ability to work?
- Unsafe walking, reaching, or handling because of chorea or incoordination
- Errors or off-task time from cognitive slowing
- Difficulty regulating behavior with supervisors or coworkers
- Absences for neurology, genetics counseling, and therapy
- Need for supervision incompatible with competitive work as the disease progresses
Does Social Security have a Listing for Huntington’s Disease?
Social Security currently has listing criteria that may apply: 11.17 (Neurodegenerative disorders of the central nervous system); 12.02 (Neurocognitive disorders). Meeting a listing requires the specific medical findings in that listing, not only the diagnosis.
- Listing 11.17: Neurodegenerative disorders of the central nervous system
- Listing 12.02: Neurocognitive disorders
Listing 11.17 covers neurodegenerative CNS disorders such as Huntington’s disease. It is met by extreme motor limitation from disorganization of motor function in two extremities, or marked physical limitation plus marked limitation in one mental area. Section 11.00P states that solely cognitive effects are evaluated under the mental listings (typically 12.02).
SSA applies Listing 11.17 when motor and combined physical-mental criteria are met. Solely cognitive Huntington disease is evaluated under 12.02. CAL processing can identify adult-onset and juvenile-onset Huntington claims quickly, but the file still must establish the clinical diagnosis. RFC remains relevant if listing criteria are not yet met or for an earlier period.
“Adult Onset Huntington Disease” and “Juvenile Onset Huntington Disease” appear on SSA’s current Compassionate Allowances list (POMS DI 23022.923 and DI 23022.785). CAL expedites identification and processing. SSA still needs medical evidence establishing the diagnosis and applicable eligibility rules. Presymptomatic gene-positive status without a clinical disorder is not a CAL claim.
Can you qualify if you do not meet an SSA Listing?
Yes. Early symptomatic HD that does not yet meet 11.17 or 12.02 may still preclude work through combined RFC.
What medical evidence may help document Huntington’s Disease?
- Neurology records documenting the clinical diagnosis and motor examination
- Genetic confirmation when obtained, interpreted with the clinical picture
- Cognitive and psychiatric evaluations
- Therapy, swallow, and nutrition notes
- Function observations of gait, chorea, and need for prompting
Testing, imaging, and laboratory studies
- HTT CAG-repeat testing when performed
- Brain imaging used in the differential diagnosis
- No genetic result alone meets Listing 11.17 without a clinical disorder
Symptomatic treatment for chorea, mood, and swallowing should be documented. Progression despite treatment is expected in HD and belongs in the longitudinal record.
How SSA may evaluate residual functional capacity
Residual functional capacity may consider motor safety, cognitive slowing, psychiatric symptoms, and other medically supported limitations when the listing criteria are not met. A positive genetic test without clinical manifestations does not by itself establish work-related functional limitations.
Supported limits may reduce walking, balancing, fingering, and exposure to heights or machinery.
Documented executive dysfunction, irritability, or depression is evaluated under 12.02 or mental RFC.
Common issues that can weaken a disability claim involving Huntington’s Disease
A claim may be harder to support when it relies only on a genetic test before clinical disease is documented, when the record lacks current motor or mental examinations, or when Compassionate Allowances status is treated as a substitute for the underlying medical and nonmedical eligibility requirements.
What may strengthen the medical documentation
A treating neurologist’s clinical diagnosis, serial motor and cognitive exams, and a clear functional timeline.
Huntington’s Disease and related medical conditions
- Alzheimer’s Disease — SSA evaluates Alzheimer-type dementia primarily as a neurocognitive disorder under Listing 12.02. Early-onset presentations may also be considered under Listing 11.17. Young-onset Alzheimer disease appears on the current CAL list; typical late-onset disease does not automatically.
- Amyotrophic Lateral Sclerosis — A progressive motor neuron disease evaluated under Listing 11.10. Adult ALS is also on SSA’s Compassionate Allowances list for expedited case processing when the documented diagnosis meets applicable rules.
- Frontotemporal Dementia — SSA evaluates frontotemporal dementia primarily as a neurocognitive disorder under Listing 12.02. Adult FTD / Pick’s disease Type A appears on the current CAL list. A personality-change complaint without a clinical diagnosis is not an approval.
- Major Depressive Disorder — Persistent depressive symptoms may be evaluated under Listing 12.04. A diagnosis does not guarantee benefits; SSA also examines severity, duration, and work-related function.
- Parkinson's Disease — A progressive movement disorder that may affect gait, hand use, speech, cognition, and stamina. SSA evaluates Parkinson's disease under Listing 11.06 for Parkinsonian syndrome.
How Brock & Stout may help
We assemble the neurology and genetic record, identify Listing 11.17 or 12.02 and CAL processing, and develop RFC when listing criteria are not met.
Frequently asked questions
Adult-onset and juvenile-onset Huntington disease appear on SSA’s current CAL list. CAL can expedite processing. SSA still must establish the clinical diagnosis and eligibility rules.
No. Presymptomatic gene-positive status is not a listing-level impairment. SSA evaluates the clinical disorder and functional limits.
Related Brock & Stout resources
Speak with a Social Security Disability attorney
If Huntington’s Disease is affecting your ability to work, Brock & Stout can review the claim, look for missing medical evidence, and discuss next steps. If we represent you, you do not owe attorney fees or case costs if the claim is denied.
Prefer to send us your information? Request a case evaluation.
This page is general educational information about Social Security Disability as of the date of this publication. It is not legal or medical advice, does not create an attorney-client relationship, and does not guarantee results. Eligibility depends on individual facts and current Social Security rules.
